Clinical trials for polyneuropathy: the role of nerve conduction studies, quantitative sensory testing, and autonomic function testing.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of clinical neurophysiology

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004691-199803000-00005PMID 9563579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrodiagnostic studies in clinical trials for motor neuron disease.

  1998cited by this paper
• Aaem minimonograph #48: Autonomic nervous system testing

  1997cited by this paper
• Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort

  1997cited by this paper
• Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy

  1996cited by this paper
• Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements.

  1996cited by this paper
• Measurement of heart rate variations: influencing factors, normal values and diagnostic impact on diabetic autonomic neuropathy.

  1995cited by this paper
• Diabetic polyneuropathy in controlled clinical trials: Consensus report of the peripheral nerve society

  1995cited by this paper
• The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

  1995cited by this paper
• Variables influencing neuropathic endpoints

  1995cited by this paper
• Inter‐ and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy

  1994cited by this paper
• Clinical Testing in Diabetic Peripheral Neuropathy

  1994cited by this paper
• Assessment of diabetic neuropathy: Definition of normal and discrimination of abnormal nerve function

  1993cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold

  1993cited by this paper
• Reproducibility of Parameters for Assessment of Diabetic Neuropathy

  1993cited by this paper
• Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Summary and recommendations.

  1992cited by this paper
• AAEM minimonograph #38: Neuropathies in connective tissue disease

  1992cited by this paper
• Variability of repeated nerve conduction studies.

  1991cited by this paper
• The Rochester Diabetic Neuropathy Study

  1991cited by this paper
• Inter‐ and intra‐examiner reliability of nerve conduction measurements in normal subjects

  1991cited by this paper
• Comparison of algorithms of testing for use in automated evaluation of sensation

  1990cited by this paper
• Meaningful Degrees of Prevention or Improvement of Nerve Conduction in Controlled Clinical Trials of Diabetic Neuropathy

  1989cited by this paper
• Evoked action potentials and conduction velocity in human sensory nerves

  1966cited by this paper

• Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.

  2024cites this paper
• Centella asiatica triterpenes for diabetic neuropathy: a randomized, double-blind, placebo-controlled, pilot clinical study.

  2018cites this paper
• Pauliina Lindholm – NEURAL MECHANISMS OF OROFACIAL PAIN – EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION

  2017cites this paper
• Association between Carotid Intima Media Thickness and Heart Rate Variability in Adults at Increased Cardiovascular Risk

  2017cites this paper
• Reduced thermal threshold in patients with Temporomandibular Disorders.

  2016cites this paper
• Outcome Measures and Clinical Assessment Instruments in Neuromuscular Disease

  2014cites this paper
• Quantitative Sensory Testing

  2014cites this paper
• Neuromuscular Update II : Mind the Gap ! Between Theory and Practice

  2013cites this paper
• Ulnar to Median Nerve Minimum F-Wave Latency Difference in Confirmation of Ulnar Neuropathy at Elbow

  2013cites this paper
• Premature aging-related peripheral neuropathy in a mouse model of progeria.

  2011cites this paper
• Management of paclitaxel-induced neurotoxicity

  2011cites this paper
• Analysis of thermal pain sensitivity and psychological profiles in different subgroups of TMD patients.

  2010cites this paper
• Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.

  2008cites this paper
• Chapter 19 – Polyneuropathies

  2007cites this paper
• Quantitative sensory testing, obstructive sleep apnea and peripheral nervous lesions

  2006cites this paper
• Peripheral neuropathy induced by microtubule-stabilizing agents.

  2006cites this paper
• Chapter 35 – Use of Neurophysiologic Techniques in Clinical Trials

  2005cites this paper
• F‐wave latency is the most reproducible NCS parameter in repeated studies performed at short intervals

  2005cites this paper
• Disturbances of Pain Perception in Disorders of the Peripheral Nervous System

  2004cites this paper
• Clinical neurophysiology and quantitative sensory testing in the investigation of orofacial pain and sensory function.

  2004cites this paper
• Two approaches to measure amplitude changes of the sensory nerve action potential over a length of nerve

  2003cites this paper
• The effect of pain on changes in heart rate during the Valsalva manoeuvre

  2003cites this paper
• Cancer and Cancer Treatment-Related Neuromuscular Disease

  2003cites this paper
• Two approaches to measure amplitude changes of the sensory nerve action potential over a length of nerve

  2003cites this paper
• Repeatability of dermatomal warm and cold sensory thresholds in patients with sciatica

  2002cites this paper
• Chapter 13 An appraisal of the role of clinical neurophysiology in toxic neuropathy

  2002cites this paper
• Peripheral neuropathy in cancer patients.

  2001cites this paper
• Reduction of paclitaxel-induced peripheral neuropathy with glutamine.

  2001cites this paper
• Thalidomide neuropathy in patients treated for metastatic prostate cancer

  2001cites this paper
• Peripheral Neuropathy in Cancer Patients

  2001cites this paper
• Measurement of somatic neuropathy for clinical practice and clinical trials

  2001cites this paper
• Neuromuscular disease: muscle

  2000cites this paper
• Quantitative sensory testing: effect of site and pressure on vibration thresholds.

  2000cites this paper
• F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy

  2000cites this paper
• Epidemiologic principles in the evaluation of suspected neurotoxic disorders.

  2000cites this paper
• Effect of simple analgesics on quantitative sensation test threshold

  1999cites this paper
• A nonpathogenic GAAGGA repeat in the Friedreich gene: Implications for pathogenesis

  1999cites this paper